113¦~«×¬y·P¬Ì­]/·s«a¬Ì­]±µºØ°T®§¤½§i

·s¥_¥«¦ÛÁʬ̭]¼È®É¯Ê³f(¦p»Ý±µºØ¬ÛÃö¬Ì­]¡A½Ð¬¢ªþªñ½Ã¥Í©Ò)


¤@. ¬y·P¬Ì­]±µºØ¨Æ¶µ»¡©ú

(¤@)          ¹ê¬I´Á¶¡

1.     ²Ä¤@¶¥¬q(113.10.01°_)

2.     ²Ä¤G¶¥¬q(113.11.01°_)

¤G. ¤¤©MªÀ°Ï±µºØ¯¸¸ê°T(65·³¥H¤W¦¨¤H¡A§K¦¬¶O)¡C

¤T.          ¬y·P¬Ì­]¨Ö©ó¤@¯ëªù¶E¶i¦æ±µºØªA°È

(!!!¦Û10/3©]¶E°_¦Ü¬Ì­]¥ÎÁj!!!)

(1)   ¦¨¤H½Ð¦Ü¤@¯ëªù¶E¸gÂå®vµû¦ô«á±µºØ

(2)   ¥¥²£°ü½Ð¦Ü°ü²£¬ìªù¶E¸gÂå®vµû¦ô«á±µºØ

(3)   °·¨àªù¶E©P¤­¤£´£¨Ñ¤½¶O¬y·P¬Ì­]±µºØªA°È¡A½Ð¤Å±¾¸¹

¦¬¶O¶µ¥Ø¡G¤W¡B¤U¤Èªù¶E150/¤¸¡B©]¶¡ªù¶E200/¤¸

¥|. °Ñ¦Ò¸ê®Æ

(¤@)          °ª­·ÀIºC©Ê¯f¯e¯f¥N½X¤@Äýªí

(¤G)          ¨u¨£¯e¯f¤ÀÃþ§Ç¸¹·JÁ`ªí

(¤T)          ¬Ì­]±µºØ¶·ª¾

 


¤@. ¬y·P¬Ì­]±µºØ¨Æ¶µ»¡©ú

¥»°|°t¦X¬F©²¬Fµ¦¡A¦Û113.10.01°_¶}©ñ±µºØ¬y·P/·s«a¬Ì­]¡A¨Ì¬Fµ¦³W¹º¤À¨â¶¥¬q¶}©ñ¡A¸Ô¦p¤Uªí©Ò¥Ü¡C

1.     ¤@¶¥¬q(113.10.01°_)

¶¥¬q¶¶§Ç

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

²Ä¤@¶¥¬q

 

113.10.01°_¦Ü¬Ì­]¥ÎÁj

65·³¥H¤WªøªÌ

(¥Á48¦~¥H«e¥X¥Í)

1.  °·«O¥d

2.  ¨­¤ÀÃÒ

150¤¸

º¡6­Ó¤ë¥H¤W¦Ü°ê¤p¤J¾Ç«e¥®¨à

1.°·«O¥d

2.¨àµ£°·±d¤â¥U

3.®aªø¦P·N®Ñ

150¤¸

¥¥°ü

1.°·«O¥d

2.¨­¤ÀÃÒ

3.¥¥°ü°·±d¤â¥U

150¤¸

°ª­·ÀIºC©Ê¯f¤H

1.°·«O¥d

2.¨­¤ÀÃÒ

3.¬ÛÃöÃÒ©ú¤å¥ó(³B¤èºà¡B¶EÂ_®Ñ)

150¤¸

¨u¨£¯e¯f±wªÌ

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. ¬ÛÃöÃÒ©ú

150¤¸

­«¤j¶Ë¯f±wªÌ

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. ­«¤j¶Ë¯fÃÒ©ú

150¤¸

°ê¤p¡B°ê¤¤¡B°ª¤¤¡B°ªÂ¾¡B¤­±M¤@¦Ü¤T¦~¯Å¾Ç¥Íµ¥

1.°·«O¥d

2.¸É±µºØ³qª¾®Ñ(¾Ç®Õ»\³¹)

3.±Ð¨|³¡¶}¥ß¤§¾Ç¥Í¨­¤ÀÃÒ©ú¬ÛÃö¤å¥ó

200¤¸

6­Ó¤ë¤ºÀ¦¨à¤§¤÷¥À

1.°·«O¥d

2.¨­¤ÀÃÒ

3.À¦¨à¥X¥ÍÃÒ©ú

150¤¸

³]Äy·s¥_¥«§C¦¬¡B¤¤§C¦¬¤J¤á

1.°·«O¥d

2.§C¦¬¡B¤¤§C¦¬¤J¤áÃÒ©ú

100¤¸

³]Äy·s¥_¥«¨­¤ß»ÙêªÌ

1.°·«O¥d

2.¨­¤ß»Ùê¤â¥U

100¤¸

¨ó§U½Ã¥Í³æ¦ìªA°È¤§²Ä¤@½u¬ÛÃö¤H­û

1.  °·«O¥d

2.  ¤u§@ÃѧOÃÒ

100¤¸

·s¥_¥«ÁÒ¤º²£«áÅ@²z¤§®a«DÂå¨Æ¤u§@¤H­û

1.°·«O¥d

2.¤u§@ÃÒ©ú¤å¥ó

100¤¸

¥»¥««È¹B¤½¥q¥q¾÷

1.  °·«O¥d

2.  ¤u§@ÃÒ©ú¤å¥ó

100¤¸

µn°O·s¥_¥«©~®a«¬¦«¨|¤H­û

1. °·«O¥d

2. »â¦³·s¥_¥«¬F©²ªÀ·|§½µn°OÃÒ©ú¤å¥ó

100¤¸

¦Û¶O¬Ì­]

±ý¦Û¶O±µºØ¤§¥Á²³

1. °·«O¥d

2. ¨­¤ÀÃÒ

¨Ìªù¶E¹ê»Ú¦¬¶O

2.     ²Ä¤G¶¥¬q(113.11.01°_)

¶¥¬q¶¶§Ç

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

²Ä¤G¶¥¬q

113.11.01°_¦Ü¬Ì­]¥ÎÁj

50-64·³¥H¤WµL°ª­·ÀIºC©Ê¯f¦¨¤H

1.°·«O¥d¡B¨­¤ÀÃÒ

150¤¸

3.     °·¨àªù¶E±µºØ®É¬q(10/5°_¦­¶E)

°·¨àªù¶E

¶g¤@

¶g¤G

¶g¤T

¶g¥|

¶g¤­

¶g¤»

¤W¤È¶E

¢½

¤U¤È¶E

¢½

¢½

¢½

¢½

¤£±µºØ¬y·P¬Ì­]

 

(¤@)          ±µºØª`·N¨Æ¶µ

1.     Âå°|±µºØ¤½¶O¬y·P¬Ì­]¡A±N¨Ì¨­¤À§O°u¦¬±¾¸¹¶O¤Î±µºØ³B¸m¶O¡C

2.     ºô¸ô¹w¬ù¸¹½X¤£¥Nªí²{³õ±µºØ¶¶§Ç¡A½Ð¨Ì²{³õ¸¹½XµP¤Î¤u§@¤H­û¤Þ¾É¬°·Ç¡C

3.     ¬I¥´·í¤Ñ½Ð°È¥²Äâ±a°·«O¥d¤Î¬ÛÃöÃÒ¥ó¡A¥¼Äâ±aªÌ¤£¥i¬I¥´¡C

4.     ªì¶E½Ð°È¥²Äâ±a°·«O¥d¤Î¨­¤ÀÃÒ¡C

5.     ¿Ô¸ß±M½u¡G

l  °·±d¿Ô¸ß±M½u¡G(02)2249-0088Âà1112

l  ÃĪ«¿Ô¸ß±M½u¡G(02)2248-9211

l  ¨ä¥L¿Ô¸ß±M½u¡G(02)2249-0088Âà1080-1082

 

¤G. ¤¤©M°ÏªÀ°Ï±µºØ¯¸¸ê°T(65·³¥H¤W¦¨¤H¡A§K¦¬¶O)

(¤@)          ªA°È®É¶¡¡G½Ð¨Ì¦U¨½¦w±Æ®É¬q«e©¹¬I¥´

¤é´Á

¦aÂI

¦a§}

ªA°È®É¶¡

10/12(¤»)

¥Á¨ÉÃÀ¤å¯S°Ï

¦Ûªvµó67¸¹

08:00-11:30

10/12(¤»)

­û¤s¸ô26¸¹

13:00-15:00

10/12(¤»)

³s«°¥«¥Á¬¡°Ê¤¤¤ß

¦w¨¹µó18¸¹2¼Ó

15:30-17:30

10/12(¤»)

­¸¾m¥«¥Á¬¡°Ê¤¤¤ß

©¾§µµó48¸¹2¼Ó

13:30-17:00

10/13(¤é)

¦wÁJ¥«¥Á¬¡°Ê¤¤¤ß

­û¤s¸ô294«Ñ7¸¹

08:30-11:30

10/13(¤é)

¤¤¥¿¨½¿ì¤½³B

³s«°¸ô347«Ñ16§Ë41¸¹

08:30-11:30

10/13(¤é)

­û¤s¨½¶°·|©Ò

­û¤s¸ô466«Ñ19¸¹

13:30-16:30

10/15(¤G)

¤å¤¸¨½¿ì¤½³B

­û¤s¸ô132«Ñ24¸¹

09:00-11:00

10/15(¤G)

¼q¥J§ÀÅbÄÖ¥æ½Ë¤¤¤ß

¼q¬üµó6«Ñ3¸¹1¼Ó

09:00-11:00

10/15(¤G)

ºÑªe®c¤g¦a¤½¼q

³s«°¸ô249¸¹

10:30-12:00

10/15(¤G)

ÀA©M¥«¥Á¬¡°Ê¬¡°Ê¤¤¤ß

¶ê³q¸ô369«Ñ2¸¹

14:00-17:00

10/16(¤T)

OK«K§Q°Ó©±(¤¤©M©y¦w©±)«e

©y¦w¸ô49¸¹

14:00-16:00

10/17(¥|)

¨Î©MªÀ°ÏÃöÃh¾ÚÂI

¤¤¤s¸ô¤G¬q2«Ñ5§Ë11¸¹

10:30-12:00

10/17(¥|)

¥ËüŶ°·|©Ò

«O¥­¸ô289¸¹

13:30-16:30

10/19(¤»)

¨q´º¨½¿ì¤½«Ç

¦¨¥\¸ô72¸¹

08:00-10:00

10/19(¤»)

¹Å¼y¨½¶°·|©Ò

­û¤s¸ô143«Ñ48-5¸¹

09:00-11:00

10/19(¤»)

ºÖµ½¥«¥Á¬¡°Ê¤¤¤ß

ºÖ¬ü¸ô301«Ñ25¸¹

10:30-12:00

10/19(¤»)

¨q®p¥«¥Á¬¡°Ê¤¤¤ß

´º¼wµó25¸¹

13:30-16:30

10/19(¤»)

´_¿³°ê¤p

´_¿³¸ô301«Ñ6¸¹

13:30-15:30

10/20(¤é)

¤s¥_¬¡°Ê¤¤¤ß

²ø·q¸ô49«Ñ29§Ë2¸¹

08:00-16:30

10/20(¤é)

±R«n¬¡°Ê¤¤¤ß

´º·sµó496«Ñ26§Ë2¸¹

08:00-10:00

10/20(¤é)

¤C¦w¶°·|©Ò

¦w¼Ö¸ô143«Ñ3¸¹

10:30-12:00

10/24(¥|)

¨q¤¯¨½¿ì¤½«Ç

¤j«iµó43«Ñ8¸¹1¼Ó

13:30-15:30

10/26(¤»)

¤[®õ®L«Â¦iªÀ°Ï

«n¤s¸ô180¸¹¤jÆU

08:00-09:30

10/26(¤»)

´_¿³¤j¼Ó

«n¤s¸ô236¸¹

10:00-12:00

10/26(¤»)

ªL¤ó©v¯¨

¤¤©M¸ô350«Ñ8§Ë1¤§2¸¹1¼Ó

14:00-16:30

 

¤T. ·s«a¬Ì­]±µºØ¨Æ¶µ»¡©ú

¤½¶O±µºØ¹ï¶H¬°65·³¥H¤WªøªÌ(48(§t)¥H«e¥X¥Í)¡A¨Ì¤£¦P±µºØ±¡§Î¡A¤À¶¥¬q¶}¥´

(¤@)        ¤½¶O¬Ì­]¡G

 

Ãþ§O

¶¥¬q

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

¤¤¥¡¤½¶O

²Ä¤@¶¥¬q

(2024.10.01°_)

¦P¬y·P¬I¥´²Ä¤@¶¥¬q¹ê¬I¹ï¶H

1.     °·«O¥d

2.     ¨­¤ÀÃÒ

150¤¸

²Ä¤G¶¥¬q

(2024.11.01°_)

¥X¥Íº¡6­Ó¤ë¥H¤WªÌ(¥¼¦C¦b²Ä¤@¶¥¬q¹ê¬I¹ï¶H)

1.     °·«O¥d

2.     ¨­¤ÀÃÒ

150¤¸

 

(¤G)        ¦Û¶O¬Ì­]¡G

Ãþ§O

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

¦Û¶O

±ý¦Û¶O±µºØ¤§¥Á²³

1.     °·«O¥d

2.     ¨­¤ÀÃÒ

¨Ìªù¶E¹ê»Ú¦¬¶O

 


 

u  ²ö¼w¯Ç¡]Spikevax¡^JN.1 COVID-19 ¬Ì­]¬ÛÃö¸ê°T

https://shh.tmu.edu.tw/upload_files/covidvacc/index.html

 

¤­.°Ñ¦Ò¸ê®Æ

(¤@)          °ª­·ÀIºC©Ê¯f¯e¯f¥N½X¤@Äýªí

ICD-10

¤jÃþ

¤ÀÃþ¦WºÙ

¤¤¤å¯f¦W

ICD-10-CM
½s½X

­^¤å¯f¦W (ICD-10-CM)

B

·P¬V¯g

¤HÃþ§K¬Ì¤£¥þ¯f¬r¯e¯f©Î·P¬V

B20,Z21

B20: Human immunodeficiency virus [HIV] disease
Z21: Asymptomatic human immunodeficiency virus [HIV] infection status

D

¦å²G©M³y¦å¾¹©x¤Î¯A¤Î§K¬Ì¾÷Â઺¯e±w

§K¬Ì¯Ê¥F¯g

D80-84

D80: Immunodeficiency with predominantly antibody defects
D81: Combined immunodeficiencies
D82: Immunodeficiency associated with other major defects
D83: Common variable immunodeficiency
D84: Other immunodeficiencies

Ãþ¦×½F¯f»P¨ä¥L

D86,D89

D86: Sarcoidosis
D89: Other disorders involving the immune mechanism, not elsewhere classified

E

¤º¤À泌¡BÀç¾i©M¥NÁ¯e¯f

¿}§¿¯f

E08-13

E08: Diabetes mellitus due to underlying condition
E09: Drug or chemical induced diabetes mellitus
E10: Type 1 diabetes mellitus
E11: Type 2 diabetes mellitus
E13: Other specified diabetes mellitus

ªÎ­D¯g

E66

E66: Obesity

Ãþ¾ý¯»ÅÜ©Ê

E85

E85: Amyloidosis

G

¯«¸g¨t²Î»P·Pı¾¹©xªº¯e¯f

¤¤¼Ï¯«¸g¨t²Îµoª¢©Ê¯e¯fªº«á¿ò¯g

G09

G09: Sequelae of inflammatory diseases of central nervous system

©¬ª÷´Ë¤ó¯f

G20

G20: Parkinson's disease

ªü¯÷®üÀq¤ó¯f»P¨ä¥L¯«¸g°h¤Æ©Ê¯e¯f

G30-32

G30: Alzheimer's disease
G31: Other degenerative diseases of nervous system, not elsewhere classified
G32: Other degenerative disorders of nervous system in diseases classified elsewhere

¦hµo©Êµw¤Æ¯g»P¨ä¥L²æÅèÀT¯e¯f

G35-37

G35: Multiple sclerosis
G36: Other acute disseminated demyelination
G37: Other demyelinating diseases of central nervous system

Åöíw¤Î­«Âеo§@

G40

G40: Epilepsy and recurrent seizures

µu¼È©Ê¸£¯Ê¦åµo§@»P¸£¦åºÞ¯e¯f©Ò­Pªº¸£¦åºÞ¯g­Ô¸s

G45-46

G45: Transient cerebral ischemic attacks and related syndromes
G46: Vascular syndromes of brain in cerebrovascular diseases 

µoª¢©Ê¤Î¬r©Ê¦hµo神¸g¯fÅÜ«á¿ò¯g

G65

G65: Sequelae of inflammatory and toxic polyneuropathies

­«¯g¦ÙµL力

G70

G70: Myasthenia gravis and other myoneural disorders

¨ä¥L¤Î¥¼¯S©w¤§¦Ù¯fÅÜ

G72

G72: Other and unspecified myopathies

I

´`Àô¨t²Î
¯e¯f

­·Àã¼ö»PºC©Ê­·Àã©Ê¤ßŦ¯f

I00-02,

I05-09

I00: Rheumatic fever without heart involvement                                
I01: Rheumatic fever with heart involvement                                I02: Rheumatic chorea
I05: Rheumatic mitral valve diseases        
I06: Rheumatic aortic valve diseases          
I07: Rheumatic tricuspid valve diseases  
I08: Multiple valve diseases                        
I09: Other rheumatic heart diseases

°ª¦åÀ£¯e¯f

I11-13

I11: Hypertensive heart disease
I12: Hypertensive chronic kidney disease
I13: Hypertensive heart and chronic kidney disease

¤ßµ±µh»P¨ä¥L¯Ê¦å©Ê¤ßŦ¯f

I20-22,

I24-25

I20: Angina pectoris
I21: ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I22: Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I24: Other acute ischemic heart diseases
I25: Chronic ischemic heart disease

ªÍ©Ê¤ßŦ¯f

I27-28

I27: Other pulmonary heart diseases
I28: Other diseases of pulmonary vessels

佤¯e¯f

I34-37

I34: Nonrheumatic mitral valve disorders


I35: Nonrheumatic aortic valve disorders


I36: Nonrheumatic tricuspid valve disorders


I37: Nonrheumatic pulmonary valve disorders

¤ß¦Ù¯fÅÜ

I42-43

I42: Cardiomyopathy
I43: Cardiomyopathy in diseases classified elsewhere

¤ßŦ¶Ç¾É
¯e¯f

I44-45,

I47-49

I44: Atrioventricular and left bundle-branch block
I45: Other conduction disorders
I47: Paroxysmal tachycardia
I48: Atrial fibrillation and flutter
I49: Other cardiac arrhythmias

¤ß°IºÜ»P
¨ä¥L

I50-51

I50: Heart failure
I51: Complications and ill-defined descriptions of heart disease

«D¥~¶Ë©Ê¸£¥X¦å

I60-62

I60: Nontraumatic subarachnoid hemorrhage
I61: Nontraumatic intracerebral hemorrhage
I62: Other and unspecified nontraumatic intracranial hemorrhage

¸£±ð¶ë

I63

I63: Cerebral infarction

¨ä¥L¸£¦åºÞ¯e¯f©Î¨ä«á¿ò¯g

I67-69

I67: Other cerebrovascular diseases
I68: Cerebrovascular disorders in diseases classified elsewhere
I69: Sequelae of cerebrovascular disease

°Ê¯ßµ°¼Ëµw¤Æ

I70

Atherosclerosis

°Ê¯ß½F

I71,72

I71: Aortic aneurysm and dissection
I72: Other aneurysm

¨ä¥L¦åºÞ
¯e¯f

I73-74,

I77, I79

I73: Other peripheral vascular diseases


I74: Arterial embolism and thrombosis


I77: Other disorders of arteries and arterioles


I79: Disorders of arteries, arterioles and capillaries in diseases classified elsewhere

J

©I§l¨t²Î
¯e¯f

¤ä®ðºÞª¢»P¨ä¥LºC©Êªý¶ë©ÊªÍ¯e¯f

J40-45

J40: Bronchitis, not specified as acute or chroni
J41: Simple and mucopurulent chronic bronchitis

J42: Unspecified chronic bronchitis
J43: Emphysema

J44: Other chronic obstructive pulmonary disease
J45: Asthma

¤ä®ðºÞ
ÂX±i¯g

J47

J47: Bronchiectasis

ªÍ¨IµÛ¯g¤Î¥~¦]©Ò­P¤§ªÍ¯e¯f

J60-70

J60: Coalworker's pneumoconiosis

J61: Pneumoconiosis due to asbestos and other mineral fibers 
J62: Pneumoconiosis due to dust containing silica
J63: Pneumoconiosis due to other inorganic dusts  

J64: Unspecified pneumoconiosis
J65: Pneumoconiosis associated with tuberculosis

J66: Airway disease due to specific organic dust
J67: Hypersensitivity pneumonitis due to organic dust

J68: Respiratory conditions due to inhalation of chemicals, gases, fumes and vapors

J69: Pneumonitis due to solids and liquids
J70: Respiratory conditions due to other external agents

¨ä¥LªÍ³¡
¯e¯f

J82,J84,J96,

J98,J99

J82: Pulmonary eosinophilia, not elsewhere classified


J84: Other interstitial pulmonary diseases


J96: Respiratory failure, not elsewhere classified


J98: Other respiratory disorders

J99: Respiratory disorders in diseases classified elsewhere

K

®ø¤Æ¨t²Î
¯e¯f

ºC©Ê¨xª¢»P¨xµw¤Æ

K70-72,

K73-76,

B18-19

K70: Alcoholic liver disease
K71: Toxic liver disease
K72: Hepatic failure
¡Anot elsewhere classified
K73: Chronic hepatitis, unspecified

K74: Fibrosis
K75: Other inflammatory disease of liver K76: other diseases of liver
B18: Chronic viral hepatitis
B19: Unspecified viral hepatitis

M

¦Ù¦×°©Àf¨t²Î¤Îµ²½l²Õ´¯e¯f

Ãþ­·Àã©ÊÃö¸`ª¢

M05-06

M05: Rheumatoid arthritis with rheumatoid factor
M06: Other rheumatoid arthritis

¥þ¨­©Ê¦ÛÅé§K¬Ì¯g­Ô¸s

M30-31, M32-34

M30: Polyarteritis nodosa and related conditions
M31: Other necrotizing vasculopathies
M32: Systemic lupus erythematosus (SLE)
M33: Dermatopolymyositis
M34: Systemic sclerosis [scleroderma]

¨ä¥Lµ²½l²Õ´¯e¯f

M35, M94.1

M35: Other systemic involvement of connective tissue
M94.1: Relapsing polychondritis

N

¥Í´Þªc§¿¨t²Î¯e¯f

µÇª¢¯g­Ô¸s

N00-01,N03,

N05

N00: Acute nephritic syndrome
N01: Rapidly progressive nephritic syndrome
N03: Chronic nephritic syndrome
N05: Unspecified nephritic syndrome

µÇ¯f¯g­Ô¸s

N04

N04: Nephrotic syndrome

ºC©ÊµÇ°IºÜ¤ÎµÇ°IºÜ¥¼©ú¥ÜªÌ

N18-19

N18: Chronic kidney disease (CKD)
N19: Unspecified kidney failure

µÇŦµäÁY

N26-27

N26: Unspecified contracted kidney

N27: Small kidney of unknown cause

Q

¥ý¤Ñ©Ê·î§Î¡BÅܧλP¬V¦âÅ鲧±`

¥ý¤Ñ©Î«á¤ÑµÊŦ¯Ê·l

Q89.01,

Z90.81

Q89.01: Asplenia (congenital)
Z90.81: Post-surgical absence of spleen

 


 

(¤G)  ¨u¨£¯e¯f¤ÀÃþ§Ç¸¹·JÁ`ªí(111.07.13)

¤ÀÃþ

§Ç¸¹

¤¤¤å¯f¦W

¡]¶È¨Ñ°Ñ¦Ò¡^

­^¤å¯f¦W(ÁY¼g)

ICD-10-CM¶EÂ_¥N½X

A.¥ý¤Ñ©Ê¥NÁ²§±`

¡·A1§¿¯À´`Àô¥NÁ²§±` Urea cycle disorders ¡]°ª¦å®ò¯g¡^

A1

01

¥ý¤Ñ©Ê§¿¯À´`Àô¥NÁ»Ùê

Congenital  Urea cycle disorders

E72.20

 

02

¥ÊÓi»Ä¦å¯g

Citrullinemia

E72.23

 

03

¤AñQâBÓi»Ä¦X¦¨–¡¯Ê¥F¯g

 

Nitroacetylglutamate synthetase deficiency, NAG synthetase deficiency

E72.29

 

04

³¾Ói»Ä®ò¥ÒñQ°òÂಾ–¡¯Ê¥F¯g

Ornithine transcarbamylase deficiency

E72.4

 

05

°ª³¾Ói»Ä¦å¯g-°ª®ò¦å¯g-°ª¥ÊÓi»Ä¦å¯g¯g­Ô¸s

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome

E72.4

¡· A2 Ói°ò»Ä/¦³¾÷»Ä¥NÁ²§±` Amino acid metabolic disorders / Organic acidemias

A2

01

Ói°ò»Ä¥NÁ¯e¯f

Amino acid metabolic disorders¡]Aminoacidopathies¡^

E72.8

 

02

°ª¯ÖÓi»Ä¦å¯g

Homocystinuria

E72.11

 

03

°ª¥Ò²¸Ói»Ä¦å¯g

Hypermethioninemia

E72.19

 

04

«D଩ʰª¥ÌÓi»Ä¦å¯g

Nonketotic hyperglycinemia

E72.51

 

05

­fଧ¿¯g

Phenylketouria

E70.0

 

06

¥|²B°ò³ãËï¯Ê¥F¯g

Tetrahydrobiopterin deficiency

E70.1

 

07

¿ò¶Ç©Ê°ª¹TÓi»Ä¦å¯g

Hereditary tyrosinemia

E70.21

 

08

·¬¿}§¿¯g

Maple syrup urine disease

E71.0

 

09

¦³¾÷»Ä¦å¯g

Organic acidemias

E71.118

 

10

²§¥³»Ä¦å¯g

Isovaleric acidemia

E71.110

 

11

¥³¤G»Ä§¿¯g¡A²Ä¤@«¬¡B²Ä¤G«¬

Glutaric aciduria type ¢¹¡B¢º

type I:E72.3

type11:E71.313

 

12

¤þ»Ä¦å¯g

Propionic acidemia

E71.121

 

13

¥Ò°ò¤þ¤G»Ä¦å¯g

Methylmalonic acidemia

E71.120

 

14

3-ßm°ò-3-¥Ò°ò¥³¤G»Ä¦å¯g

3-Hydroxy-3-methyl-methylglutaric acidemia

E71.118

 

15

¨å«¬­fଧ¿¯g¦X¨Ö½©¿}–¡¦P³ÁªÞ¿}–¡¯Ê¥F¯g

PAH type PKU combine with Sucrase-isomaltase deficiency

E74.31+E70.0

 

16

°ªÂ÷Ói°ò»Ä¦å¯g

Hyperlysinemia

E72.3

 

17

²ÕÓi»Ä¦å¯g

Histidinemia

E70.41

 

18

¤T¥Ò°ò¤Ú¨§ñQ»²–¡Aßn¤Æ»Ã¯À¯Ê¥F¯g

3-Methylcrotonyl-CoA carboxylase deficiency

E71.19

 

19

¦hµo©Êßn¤Æ–¡¯Ê¥F¯g

Multiple carboxylase deficiency

D81.819

 

20

°ª²ãÓi»Ä¦å¯g

Hyperprolinemia

E72.59

 

21

ªÚ­»±ÚL-Ói°ò»ÄÃþ²æßn°ò–¡¯Ê¥F¯g

Aromatic L-amino acid decarboxylase deficiency

E70.9

 

22

¹TÓi»Äßm¤Æ–¡¯Ê¥F¯g

Tyrosine hydroxylase deficiency

E70.20

 

23

¥Ò°ò¤þ¤G»Ä¦å¯g¨Ö°ª¯ÖÓi»Ä¦å¯g¡]Cbl C«¬¡^

Cobalamin C defect ¡]Methylmalonic aciduria and Homocystinuria, cbl C type¡^

E71.120+E72.11

¡· A3¯×½èÀx¿n

A3

01

°ª³·¤ó¯g

Gaucher¡¦s disease

E75.22

 

02

GM1/GM2¯«¸g¸`–£¯×Àx¿n¯g

GM1/GM2 gangliosidosis

GM1:E75.19

GM2: E75.00

 

03

Fabry ¤ó¯g

Fabry disease

E75.21

 

04

Niemann-Pick¤ó¯g¡AÀTÅèÁC¯×Àx¿n¯g

Niemann-Pick disease

E75.240:Type A

E75.241:Type B

E75.242:Type C

E75.243:Type D

E75.248:other

E75.249:unspecified

 

05

MLD¯g­Ô¸s

Metachromatic Leukodystrophy¡]MLD¡^

E75.25

 

06

²y²Ó­M¸£¥Õ½è¥¢¾i¯g

Globoid Cell Leukodystrophy (Krabbe¡¦s  disease)

E75.23

 

07

À¦¨à«¬·»–¡Åé»Ä©Ê¯×ªÕ–¡¯Ê¥F¯g¡]¤SºÙ¥îº¸°Ò¤ó¯g¡^

Infantile form Lysosomal Acid Lipase Deficiency ¡]Wolman Disease¡^

E75.5

¡·A4ºÒ¤ô¤Æ¦Xª«¥NÁ²§±`

A4

01

¥b¨Å¿}¦å¯g

Galactosemia

E74.21

 

02